RedPath Integrated Pathology develops molecular diagnostics for cancer.
Business Model:
Revenue: $3M
Employees: 51-200
RedPath was acquired by
Interpace Biosciences.
The acquisition happend on 2014-11-03.
Details of the transaction were not public
Address: 300 Interpace Parkway
City: Parsippany
State: NJ
Zip: 07054
Country: US
RedPath Integrated Pathology develops molecular diagnostics for cancer.
Contact Phone:
+18557766419
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2006 | Series A | $0 |
CID Capital HealthCare Ventures HMA Capital Partners Inflexion Partners NewSpring CID Capital HealthCare Ventures HMA Capital Partners Inflexion Partners NewSpring |
4/2013 | Debt Financing | $612.5k | 8/2012 | Debt Financing | $588.2k | 5/2011 | Venture Round | 1 | $1.6M |
Plymouth Growth Plymouth Growth |
8/2006 | Pre Seed Round | 1 | $100k |
Pittsburgh Life Sciences Greenhouse Pittsburgh Life Sciences Greenhouse |
12/2006 | Series A | 5 | $6.5M |
CID Capital HealthCare Ventures HMA Capital Partners Inflexion Partners NewSpring CID Capital HealthCare Ventures HMA Capital Partners Inflexion Partners NewSpring |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|